SARS-CoV-2 IgG seroprevalence in the Okinawa Main Island and remote islands in Okinawa, Japan, 2020-2021

Kenji Mizumoto, Yusuke Shimakawa, Yoshiaki Aizawa, Christian Butcher, Naomi Chibana, Mary Collins, Kohei Kameya, Tae Gyun Kim, Satoshi Koyama, Ryota Matsuyama, Melissa M. Matthews, Tomoari Mori, Tetsuharu Nagamoto, Masashi Narita, Ryosuke Omori, Noriko Shibata, Satoshi Shibata, Souichi Shiiki, Syunichi Takakura, Naoki Toyozato, Hiroyuki Tsuchiya, Matthias Wolf, Shuhei Yokoyama, Sho Yonaha, Yoshihiro Takayama
doi: https://doi.org/10.1101/2022.03.02.22271759

Data Availability

The data that support the findings of this study are available from the corresponding author (Dr. Kenji Mizumoto) and Okinawa Prefecture Government, but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of Okinawa Prefecture Government.

Back to top
Posted March 03, 2022.
Download PDF
Data/Code
Email
SARS-CoV-2 IgG seroprevalence in the Okinawa Main Island and remote islands in Okinawa, Japan, 2020-2021
Kenji Mizumoto, Yusuke Shimakawa, Yoshiaki Aizawa, Christian Butcher, Naomi Chibana, Mary Collins, Kohei Kameya, Tae Gyun Kim, Satoshi Koyama, Ryota Matsuyama, Melissa M. Matthews, Tomoari Mori, Tetsuharu Nagamoto, Masashi Narita, Ryosuke Omori, Noriko Shibata, Satoshi Shibata, Souichi Shiiki, Syunichi Takakura, Naoki Toyozato, Hiroyuki Tsuchiya, Matthias Wolf, Shuhei Yokoyama, Sho Yonaha, Yoshihiro Takayama
medRxiv 2022.03.02.22271759; doi: https://doi.org/10.1101/2022.03.02.22271759
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area